Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV

PHARMACOGENOMICS · Published 2026-07-22 · DOI 10.1080/14622416.2026.2698921

Free full text

Authors (15)

Zinhle Cindi, Katie M. Cardone, Yuki Bradford, Molly A. Hall, Hannah Kim, Eric S. Daar, Roy Gulick, Sharon A. Riddler, Marijana Vujkovic, Kyong-Mi Chang, Philip S. Tsao, Phumla Sinxadi, David W. Haas, Marylyn D. Ritchie, VA Million Veteran Program

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Cindi, Z., Cardone, K., Bradford, Y., et al. (2026). Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV. PHARMACOGENOMICS. https://doi.org/10.1080/14622416.2026.2698921

Related articles

• HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia · Intervirology · 2021 · Cites or is cited by this article
• How to implement pre-emptive pharmacogenetic testing in the acute hospital setting · PHARMACOGENOMICS · 2025 · Same journal
• Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe · PHARMACOGENOMICS · 2025 · Same journal
• ADIPOQ genotypes and haplotypes, circulating adiponectin levels and responsiveness to antihypertensive therapy in preeclampsia · PHARMACOGENOMICS · 2025 · Same journal
• UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients · PHARMACOGENOMICS · 2025 · Same journal
• Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization · PHARMACOGENOMICS · 2025 · Same journal
• Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes · PHARMACOGENOMICS · 2025 · Same journal
• Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis · PHARMACOGENOMICS · 2025 · Same journal
• Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine · PHARMACOGENOMICS · 2026 · Same journal
• Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use · PHARMACOGENOMICS · 2026 · Same journal